About iCardiac Technologies
iCardiac Technologies is a company based in Rochester (United States) founded in 2006 was acquired by Clario in December 2017.. iCardiac Technologies has raised $4 million across 3 funding rounds from investors including Norwest Venture Partners, Clario and Advantage Capital. iCardiac Technologies operates in a competitive market with competitors including Celerion, Altasciences, Ask Gene Pharma, Open Orphan and AWAKN, among others.
- Headquarter Rochester, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4 M (USD)
in 3 rounds
-
Latest Funding Round
-
Investors
Norwest Venture Partners
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Clario
(Dec 04, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of iCardiac Technologies
iCardiac Technologies has successfully raised a total of $4M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
-
First Round
First Round
(07 Nov 2006)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2014 | Amount | Series C - iCardiac Technologies | Valuation |
investors |
|
| Nov, 2007 | Amount | Series B - iCardiac Technologies | Valuation |
investors |
|
| Nov, 2006 | Amount | Series A - iCardiac Technologies | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in iCardiac Technologies
iCardiac Technologies has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Norwest Venture Partners, Clario and Advantage Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and growth equity firm providing investments and resources to entrepreneurs in various sectors.
|
Founded Year | Domain | Location | |
|
Private equity investment firm
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by iCardiac Technologies
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - iCardiac Technologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Icardiac Technologies Comparisons
Competitors of iCardiac Technologies
iCardiac Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celerion, Altasciences, Ask Gene Pharma, Open Orphan and AWAKN, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Early clinical research services are provided for drug development.
|
|
| domain | founded_year | HQ Location |
Early phase clinical research services are provided in North America.
|
|
| domain | founded_year | HQ Location |
Biosimilars and biosuperiors are developed and commercialized in biotechnology.
|
|
| domain | founded_year | HQ Location |
Provider of testing vaccines & antivirals and CRO pharmaceutical services
|
|
| domain | founded_year | HQ Location |
CRO focused on early stage clinical trial research
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Icardiac Technologies
Frequently Asked Questions about iCardiac Technologies
When was iCardiac Technologies founded?
iCardiac Technologies was founded in 2006.
Where is iCardiac Technologies located?
iCardiac Technologies is headquartered in Rochester, United States.
Is iCardiac Technologies a funded company?
iCardiac Technologies is a funded company, having raised a total of $4M across 3 funding rounds to date. The company's 1st funding round was a Series A of $4M, raised on Nov 07, 2006.
What does iCardiac Technologies do?
iCardiac Technologies was founded in 2006 in Rochester, United States, within the biopharmaceutical sector. ECG core laboratory services for cardiac safety assessments are offered, utilizing the iClinica platform to analyze data from First-in-Human to Phase III studies, including Thorough QT evaluations. Respiratory and electronic patient-reported outcome services were added through the 2015 acquisition of nSpire Healths clinical trials division. Operations support major biopharma firms alongside smaller entities.
Who are the top competitors of iCardiac Technologies?
iCardiac Technologies's top competitors include Celerion, Ask Gene Pharma and HMR London.
Who are iCardiac Technologies's investors?
iCardiac Technologies has 6 investors. Key investors include Norwest Venture Partners, Clario, Advantage Capital, Trillium Group, and Stonehenge Growth Equity Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.